Telomerase synthesizes telomeric DNA repeats at the ends of eukaryotic chromosomes. The RNA component of the enzyme (hTR) provides the template for telomere synthesis, which is catalyzed by telomerase reverse transcriptase (hTERT). Little is known regarding the subcellular localization of hTR and hTERT, and the pathway by which telomerase is assembled. Here we report the first glimpse of the detailed subcellular localization of endogenous hTR in human cells, which we obtained by fluorescence in situ hybridization (FISH). Our studies have revealed a distinctive hTR localization pattern in cancer cells. We have found that hTR accumulates within intranuclear foci called Cajal bodies in all typical tumor-derived cell lines examined (in which telomerase is active), but not in primary or ALT cells (where little or no hTERT is present). Accumulation of hTR in the Cajal bodies of primary cells is induced when hTERT is ectopically expressed. Moreover, we report that hTERT is also found in Cajal bodies. Our data suggests that Cajal bodies are involved in the assembly and/or function of human telomerase.
Introduction
Telomeres are nucleoprotein structures that cap the ends of linear eukaryotic chromosomes. In all vertebrates, telomeres consist of tandem TTAGGG DNA repeats and associated proteins (Moyzis et al., 1988; Meyne et al., 1989; de Lange, 2002) . The function of telomeres is to protect chromosomes from degradation, recombination and end-to-end fusion (McEachern et al., 2000; Bertuch, 2002; Harrington and Robinson, 2002) . Maintenance of telomere length is critical for genomic stability. Telomeres are synthesized by telomerase, a unique DNA polymerase that minimally consists of telomerase RNA and reverse transcriptase subunits (hTR and hTERT respectively in humans) (Feng et al., 1995; Meyerson et al., 1997; Nakamura et al., 1997; Nakamura and Cech, 1998) .
Telomerase uses a short sequence within its integral RNA as a template for the synthesis of telomeric DNA by the hTERT subunit.
In humans, activation of telomerase appears to be an essential, limiting step in cellular immortalization and tumor progression. While telomerase activity is not detected in most adult somatic tissues, telomerase activity is present in greater than 90% of over 2,000 malignant tumors examined (Shay and Bacchetti, 1997) .
hTERT is normally the limiting determinant of telomerase activity. hTR is present in both normal and cancer cells (Feng et al., 1995; Avilion et al., 1996; Yi et al., 1999) . In contrast, hTERT is undetectable in most normal adult cells and tissues, but is readily detected in most cancer cells and primary tumors (Meyerson et al., 1997; Nakamura et al., 1997; Kolquist et al., 1998) . Recently, trace levels of hTERT and telomerase activity have been detected in cultured human fibroblasts however the amount of telomerase present is insufficient to prevent steady erosion of telomere length during cell division . Most cancer cells maintain telomeres, and the ability to divide indefinitely, by upregulating hTERT expression and telomerase activity (Kim et al., 1994; Shay and Bacchetti, 1997; Collins and Mitchell, 2002; Cong et al., 2002; . Moreover, ectopic expression of hTERT in a number of primary cells re-instates telomerase activity and immortalizes the cells (Bodnar et al., 1998; Nakayama et al., 1998; Vaziri and Benchimol, 1998; Hahn et al., 1999; Morales et al., 1999) .
Despite the importance of telomerase to chromosome maintenance, cellular immortalization, and oncogenesis, little is known about the essential steps in the generation of the enzyme from individual RNA and protein components including how or where within the cell hTR and hTERT assemble to form telomerase. The intracellular localization of YFP-or GFP-hTERT fusion proteins in human cell lines has recently been reported. These studies indicate that hTERT is found throughout the nucleoplasm and is concentrated in nucleoli (Etheridge et al., 2002; Wong et al., 2002; Yang et al., 2002) . Interestingly, exogenous hTERT undergoes changes in distribution between nucleoli and the nucleoplasm in response to cell cycle phase, expression of viral oncogenes (cellular transformation), and double-stranded DNA breaks (Wong et al., 2002) .
The existing information about the trafficking and subcellular localization of vertebrate telomerase RNA within the nucleus is primarily from micro-injection studies in Xenopus oocytes that addressed the early trafficking patterns of telomerase RNA. This work indicates that telomerase RNA localizes to Cajal bodies and nucleoli at various times (Narayanan et al., 1999; Lukowiak et al., 2001 ). The nucleolus is well-known as the site of assembly of ribosomes (Olson et al., 2002) . Cajal bodies are dynamic, spherical structures present in plant and animal cell nuclei (Matera, 1999; Gall, 2000; Carmo-Fonseca, 2002; Ogg and Lamond, 2002) that have recently been implicated as sites of post-transcriptional RNA modification and assembly of various RNPs ;. The micro-injection studies revealed that the box H/ACA motif found in hTR and all other vertebrate telomerase RNAs (Mitchell et al., 1999a; Chen et al., 2000) plays a role in the subcellular localization of the RNA. The H/ACA motif is characterisitic of the H/ACA RNAs, small nucleolar (sno)RNAs and small Cajal body (sca)RNAs that guide nucleotide modification (pseudouridylation) of prerRNA within the nucleolus, or of snRNAs in the Cajal body, respectively (Kiss, 2002; Terns and Terns, 2002) . Like snoRNAs, telomerase RNA is not exported to the cytoplasm but is retained within the nucleus (Lukowiak et al., 2001) . The H/ACA domain of hTR has been shown to be responsible for retention of the RNA within the nucleus (the cellular compartment where telomere synthesis occurs) and localization to the nucleolus (Lukowiak et al., 2001) . In addition to its roles in localization, the H/ACA domain mediates the binding of four H/ACA snoRNA-binding proteins to hTR (dyskerin, GAR1, NHP2, and NOP10) (Mitchell et al., 1999b; Dragon et al., 2000; Pogacic et al., 2000; Dez et al., 2001) and is important for the metabolic stability of the RNA (Mitchell et al., 1999a; Lukowiak et al., 2001; Fu and Collins, 2003) .
The detailed subcellular localization of endogenous hTR in human cells has not been reported. The presence of hTR in a variety of cancerous, pre-cancerous, and normal cells has been demonstrated by low resolution in situ hybridization primarily of histological tissue sections (reviewed in (Dhaene et al., 2000) ).
These studies indicate that hTR is primarily or exclusively located in the nucleus. Subcellular fractionation of HeLa cells has also shown that the majority of hTR is in the nucleus and that a small percentage (~7%) is found in a biochemical fraction enriched in nucleoli (Mitchell et al., 1999a) .
In this work, we have developed a specific and sensitive FISH assay and have performed the first detailed analysis of the subcellular localization of hTR in normal and cancer human cell lines. We have found that hTR accumulates in Cajal bodies in telomerase-positive cancer cell lines but not in primary cell lines, which lack hTERT and telomerase activity, or in U2OS cells, an atypical cancer line that expresses hTR but not hTERT and maintains telomeres by an alternative mechanism (i.e. an ALT (alternative lengthening of telomeres) cell line (Henson et al., 2002) ). The accumulation and detection of hTR in nuclear foci
including Cajal bodies appears to be dependent on hTERT expression and was detected in hTERT-transfected fibroblasts but not untransfected fibroblasts. We did not detect accumulation of hTR at PML bodies, gems or telomeres. Finally, we have found that YFP-tagged hTERT also specifically localizes to Cajal bodies. These findings implicate the Cajal body as a site of telomerase biogenesis and/or function. Table 1 shows the cell lines and media used in these experiments. All cells were cultured at 37°C under 5% CO 2 .
Materials and Methods

Cell lines
hTR fluorescence in situ hybridization (FISH)
All probes were aminoallyl-T-modified deoxyoligonucleotides synthesized by OPERON. The T* in the probe sequences indicates aminoallyl-thymine. Briefly, cells were grown on coverslips for 18 to 24 h, rinsed once with 1 × PBS and fixed with 4% formaldehyde (37% liquid stock from Electron Microscope Sciences), 10% acetic acid, 1 × PBS (137 mM NaCl, 2.7 mM KCl, 10 mM Na 2 HPO 4 , 1.4 mM KH 2 PO 4 , pH 7.4) for 10 min at room temperature. After two washes with PBS, cells were permeablized by treatment with 70% ethanol overnight at 4 °C. Cells were rehydrated for 5 min at room temperature in 2 × SSC, 50% formamide and prehybridized with a solution of 10% dextran sulfate (Sigma), 2 mM vanadyl ribonucleotide complex (GIBCO BRL), 0.02% RNase-free BSA (Sigma), 40 µg E. coli tRNA (Roche), 2 × SSC, 50% formamide for 1 h at 37°C. Cells were then hybridized for 4 h at 37°C in 40 µl of the prehybridization solution described above containing a total of 80 ng of fluorescently-labeled DNA probe. After hybridization, cells were washed twice with 2 × SSC, 50% formamide for 30 min at 37°C. Slides were mounted in 90% glycerol, 1 × PBS, 1 mg/ml p-phenylediamine, 0.1 µg/ml DAPI.
RNase treatment
After permeabilization in 70% ethanol overnight, cells were rehydrated in 1 × PBS containing 1.5 mM MgCl 2 at room temperature for 5 min. The cells were incubated with RNase A (0.2 mg/ml) at 37°C for 2 h. hTR FISH was performed after the cells were washed two times with 2 × SSC, 50% formamide for 10 min at 37°C.
Indirect Immunofluorescence
Following hTR FISH, cells were washed again with PBS at room temperature twice for 10 min per wash. Cells were incubated with one or two of the following antibodies at the indicated dilution for 1 h at room temperature: R288, rabbit antip80 coilin (1:1000) (Andrade et al., 1991) or mouse anti-p80 coilin (1:100) (Almeida et al., 1998) ; 5E10, mouse anti-PML (1:10) (Stuurman et al., 1992) ; mouse anti-SMN (1:1000) (BD); rabbit anti-TRF2 (1:100) (Karlseder et al., 1999) ; rabbit anti-TRF1 (1:100) (Smith and de Lange, 1999) . Cells were washed with PBS for 3 × 10 min at room temperature followed by incubation with 1:100
Cy2-conjugated goat anti-rabbit or anti-mouse IgG (Jackson ImmnoResearch), 1:50 Alexa Fluor 350-conjugated goat anti-rabbit IgG (Molecular Probes), or 1:100 Texas Red conjugated goat anti-mouse IgG (Jackson ImmnoResearch) for 1 h at room temperature. All antibodies were diluted in PBST (0.05% Tween 20 in PBS). After three 10 min washes in PBS, slides were mounted as described above.
Transfection and visualization of YFP-hTERT
HeLa cells were grown on coverslips for 18 h and then transiently transfected with 1 µg of either plasmid pYFP-hTERT (Etheridge et al., 2002) or control plasmid pEGFP-N1 (Clontech) using LipofectAMINE 2000 (Invitrogen) reagent according to the manufacturer's instruction. 24 h after transfection, cells were extracted in 0.5% Triton X-100 in CSK (10 mM PIPES, pH 6.8, 300 mM sucrose, 100 mM NaCl, 1 mM EGTA, 3 mM MgCl 2 ) for 1 min at 4°C. Coverslips were washed 3 times in 1 × PBS. Cells were then fixed in 4% formaldehyde in PBS for 10 minutes at room temperature, washed twice with 1 × PBS, and indirect immunofluorescence with anti-p80 coilin antibodies was performed as described above.
Microscopy
Analysis was performed on a Zeiss Axiovert S100 inverted fluorescence microscope. All images were acquired at 63 × magnification using a cooled charge-coupled device camera (Quantix-Photometrics) and IP Lab Spectrum software.
Results
Detection of the subcellular localization of human telomerase RNA
We have established a fluorescence in situ hybridization (FISH) technique to determine the subcellular localization of hTR in human cells. We designed two probes complementary to different regions in the 5' domain of hTR ( Figure 1A and see Materials and Methods). Upon hybridization with either probe, 1-5 bright foci were observed in the nuclei of HeLa cells. Maximal hTR signal was observed when both probes were used in combination ( Figure 1B showing that telomerase RNA, rather than the telomerase RNA gene, is being detected ( Figure 1C) . Furthermore, signals were not observed in VA13 cells, an unusual ALT cell line that lacks hTR transcripts (as well as hTERT) (Bryan et al., 1997b; Guiducci et al., 2001) (Figure 1C ).
In the course of these studies, we found that hTR probes spanning nucleotides 37-44 gave false positive FISH signals (i.e. occurring in hTR-negative VA13 cells). As previously noted (Lukowiak et al., 2001) , nts 37-44 of hTR (AUUUUUUUG) match a consensus Sm protein binding site found in ubiquitously expressed and relatively abundant spliceosomal snRNAs. The false positive signals observed with probes that included this region co-localized with Sm proteins indicating that those probes recognized snRNAs. These results suggest caution with the use of probes against nts 37-44 of hTR and reevaluation of previous in situ experiments employing full-length hTR probes (reviewed in (Dhaene et al., 2000) ).
hTR accumulates in intranuclear foci in telomerase-positive cancer cells, but not telomerase-negative primary cells.
Telomerase activity is readily detected in the majority of human cancer cells, but not in the majority of normal cells. While hTERT is selectively expressed in most cancer cells, hTR is expressed in both normal and cancer cells (Feng et al., 1995; Avilion et al., 1996; Yi et al., 1999) . With this in mind, we investigated whether the localization of hTR differed between cancer and normal cell lines. To test whether similar hTR foci are also found in normal cell lines, hTR FISH was performed on primary somatic cell lines. Interestingly, no accumulation of hTR at nuclear foci was observed in the normal primary fibroblast cell lines BJ and IMR-90, or the smooth muscle cell line 2yo ( Figure 2B ). hTR levels are generally lower in normal cells than cancer cells (Yi et al., 1999; Yi et al., 2001 ), however the difference in localization pattern is not likely due to a simple difference in hTR levels. The amount of hTR present in particular primary cells that we examined (e.g. BJ and IMR90 fibroblasts) is statistically equivalent to the amount measured for DU145 cancer cells (Yi et al., 2001) , where localization to foci is observed (data not shown and see Figure 4) . Thus, the total amount of hTR present in normal cells is not below the level that can be detected by our FISH procedure when localized as in cancer cells. The above data indicate that the distribution of hTR differs in normal and cancer cells; hTR accumulates within intranuclear foci in cancer cells (where telomerase assembly is presumably ongoing) but not in normal cell lines (where little or no telomerase is made).
hTR accumulates in Cajal bodies in cancer cells
We next sought to determine the identity of the spherical nuclear foci that accumulated hTR in the tumor-derived cells. These foci are similar in size and shape to several nuclear bodies, including PML (promyelocytic leukemia) bodies and Cajal bodies. We performed double labeling experiments to simultaneously evaluate the localization of hTR (via FISH) and these nuclear bodies (via immunofluorescence using antibodies against specific marker proteins).
The PML (promyelocytic leukemia) protein is present in PML bodies and has been implicated in the processes of cell proliferation, apoptosis and senescence (reviewed in (Maul et al., 2000; Zhong et al., 2000; Borden, 2002; Salomoni and Pandolfi, 2002) ). Furthermore, specialized PML bodies, APBs (ALT associated PML bodies), are found in telomerase-negative ALT cells (Yeager et al., 1999; Henson et al., 2002) . However, as can be observed in Figure 3 (top panel), no co-localization of hTR and the PML protein was observed in HeLa cells, indicating that hTR does not accumulate in PML bodies.
Previously, we had shown that telomerase RNA associates with Cajal bodies in Xenopus oocytes (Lukowiak et al., 2001) . Cajal bodies are thought to serve as centers of biogenesis for several nuclear RNPs (reviewed in (Gall, 2000; Terns and Terns, 2001; Carmo-Fonseca, 2002; Ogg and Lamond, 2002) . It is currently hypothesized that the SMN complex (SMN and six other proteins of the gemin family) mediates the assembly of RNPs including spliceosomes, snoRNPs, and transcriptosomes within Cajal bodies (Liu and Dreyfuss, 1996; Terns and Terns, 2001; Meister et al., 2002; Paushkin et al., 2002) . SMN is the protein implicated in the fatal neuromuscular disease, spinal muscular atrophy (SMA) (Lefebvre et al., 1995) . Recent reports indicate a physical association of telomerase and SMN (Bachand et al., 2002; Whitehead et al., 2002) . In HeLa cells, there was a precise co-localization between hTR and the Cajal body marker protein, coilin We also investigated whether hTR is present within gems in related cell lines where these structures are observed. Gems are nuclear bodies that also contain the SMN complex (Liu and Dreyfuss, 1996; Meister et al., 2002; Paushkin et al., 2002) . The name gems (for gemini or twin) was assigned based on the initial observation that these nuclear bodies were found to be immediately adjacent to or co-incident with Cajal bodies (Liu and Dreyfuss, 1996) . Subsequent localization studies found that gems and Cajal bodies are merged, indistinguishable structures that contain coilin and SMN in most human cell lines (including those used in this study except where noted) (Matera and Frey, 1998; Carvalho et al., 1999; Young et al., 2002) . We have examined hTR localization in two special HeLa cell lines, in which gems are distinct structures that are enriched in SMN and coilin methylation is reduced (Hebert et al., 2002) .
Specifically, we performed triple labeling of hTR, coilin and SMN in HeLa-PV and HeLa-KN cells. In all cases, hTR accumulated in Cajal bodies, but never in gems (Figure 3 , third panel), suggesting that hTR does not simply co-localize with SMN, and that coilin methylation and SMN and are not likely required for recruitment of hTR to Cajal bodies.
We also tested whether any of the hTR-containing foci were associated with telomeres, the site where telomerase functions. Using antibodies against telomere binding proteins TRF1 and TRF2, we found that hTR signals do not typically overlap with telomeres ( Figure 3 , lower panel and data not shown). In a small fraction of cells, at a few telomeres, we did observe co-localization of hTR (within Cajal bodies) (data not shown). However, the low frequency of the colocalization made it difficult to distinguish from random co-localization of Cajal bodies with the numerous telomeres. We cannot exclude the possibility that low levels of hTR are present at telomeres (or other sites) due to detection limits of the FISH approach. Our data suggests that hTR is present in Cajal bodies and that the Cajal bodies are not usually found at telomeres. (Yi et al., 2001) ) and thus the appearance of hTR in foci could reflect increases in hTR levels as well as redistribution of the RNA. The expression of hTERT in these cells also initiates the assembly of telomerase, which may account for the redistribution of hTR.
Unlike cancer cells, primary human cells do not frequently display prominent
Cajal bodies (Spector et al., 1992; Carmo-Fonseca et al., 1993) and hTRcontaining foci observed in the BJ-hTERT and 2yo-hTERT cells generally did not co-localize with coilin, SMN or PML proteins (data not shown). Thus, in contrast to the foci observed in cancer cells, most of the hTR-containing foci in normal cells ectopically expressing hTERT did not correspond to Cajal bodies and currently remain unidentified. However, hTR co-localized with the infrequent Cajal bodies observed in BJ-hTERT and 2yo-hTERT cells, but not with those found in BJ or 2yo cells ( Figure 5B and data not shown). These results suggest that accumulation of hTR in Cajal bodies is dependent on hTERT expression.
Finally, we also examined hTR localization in cancer cells that contain numerous Cajal bodies and express hTR but not hTERT. U2OS is an osteosarcomaderived ALT line (Bryan et al., 1997a) . We were unable to detect hTR in foci within the nuclei of these cells, despite the presence of numerous Cajal bodies ( Figure 5C ). Taken together, the results indicate the importance of hTERT expression on hTR accumulation in Cajal bodies.
hTERT also localizes to Cajal bodies
Given that hTR is targeted to Cajal bodies in cancer cells where telomerase is active and hTERT is expressed, we asked if hTERT also localizes to these structures. Previous studies have shown that hTERT is present in nucleoli and is also distributed throughout the nucleoplasm (Etheridge et al., 2002; Wong et al., 2002; Yang et al., 2002) . The high levels of YFP-TERT protein present in the nucleoplasm of transfected cells in our earlier analysis (Etheridge et al., 2002) Here we consider the significance of the localization of telomerase to Cajal bodies in the context of our current knowledge.
Cajal Bodies as sites of telomerase biogenesis
We consider it likely that the Cajal body is the site where hTR and hTERT interact to form an active enzyme. Our results show that both of the key components of telomerase, hTR and hTERT, are found in Cajal bodies (Figures   3 and 6) . Moreover, we find that hTR accumulates in Cajal bodies specifically in cells where telomerase assembly is presumably ongoing (Figures 1-4) , consistent with the notion that the Cajal body is the site of assembly. No accumulation was observed in either tumor-derived (ALT) or normal cells in which hTERT is reduced or absent and telomerase is not readily detectable (Figures 2 and 5) . Furthermore, ectopic expression of hTERT (and telomerase activity) in primary fibroblasts or smooth muscle cells resulted in accumulation of hTR in Cajal bodies ( Figure 5 ). The hypothesis that telomerase assembly takes place within Cajal bodies is also based on considerable evidence implicating the Cajal body as the site of assembly of a variety of cellular RNPs (reviewed in (Matera, 1999; Gall, 2000; Terns and Terns, 2001; Carmo-Fonseca, 2002; Ogg and Lamond, 2002) ). An implication of our findings is that Cajal body localization of hTR could serve as a marker for telomerase-positive cells.
Within Cajal bodies, the assembly of hTR and hTERT into active RNP complexes may be mediated the SMN (survival of motor neuron) complex. This macromolecular complex consists of the SMN protein (the spinal muscular atrophy disease protein) and six additional protein components called gemins 2-7, and is present in Cajal bodies of most cells (Liu and Dreyfuss, 1996; Matera and Frey, 1998; Carvalho et al., 1999; Young et al., 2002) . Growing evidence indicates that SMN chaperones the assembly of several cellular RNPs, including both snRNPs and snoRNPs (reviewed in Meister et al., 2002; Paushkin et al., 2002) ). Recent data suggests SMN may also play a role in telomerase biogenesis, as SMN directly interacts with the telomeraseassociated protein GAR1 (Whitehead et al., 2002) and antibodies against SMN immunoprecipitate catalytically active telomerase (Bachand et al., 2002) .
Additional steps in telomerase biogenesis may also occur in the Cajal body. For example, hTR is associated with the H/ACA snoRNA binding proteins dyskerin (Mitchell et al., 1999a) , GAR1 , NHP2, and NOP10 Dez et al., 2001) in vivo. The H/ACA snoRNP proteins are found in Cajal bodies (Gall, 2000; Pogacic et al., 2000; Terns and Terns, 2002) and may assemble with telomerase here. Recent studies also suggest that the Cajal body is the site of post-transcriptional modification (ribose methylation and pseudouridylation) of some RNAs by the guide RNAs that reside in this structure (scaRNAs, the small Cajal body RNAs) (Darzacq et al., 2002; Kiss et al., 2002) .
Like most other stable cellular RNAs, hTR likely undergoes post-transcriptional nucleotide modifications that influence the stability and function of the RNA.
Conceivably, hTR modifications occur within Cajal bodies.
Studies using the Xenopus oocyte system provided the first evidence that vertebrate telomerase RNA localizes to Cajal bodies. Fluorescently labeled human or Xenopus telomerase RNA is specifically targeted to Cajal bodies (and nucleoli) following microinjection of the RNA into Xenopus oocyte nuclei (Narayanan et al., 1999; Lukowiak et al., 2001) . Taken together with the findings of this study (that hTR localizes to Cajal bodies in a variety of human cell lines) the evidence indicates that hTR localization to Cajal bodies is a common step in the biogenesis of vertebrate telomerase. Interestingly, ciliate telomerase RNA is also predominantly localized to spherical intranuclear foci, some of which may be Cajal bodies (Fang and Cech, 1995) . The hTR-containing foci in ciliates contain hypermethylated RNA, a hallmark feature of Cajal bodies found in other eukaryotes (Fang and Cech, 1995) . Thus, Cajal bodies appear to be a component of the telomerase biogenesis pathway for a variety of diverse eukaryotes.
Cajal Bodies and Telomerase Function
In telomerase-positive cells, active telomerase RNPs ultimately encounter telomeres to carry out telomere replication. In this study, we were generally unable to detect hTR at the telomeres. This may reflect the detection limit of the FISH procedure given that only a few molecules of hTR may function at each telomere. In addition, hTR may only interact with these structures transiently.
For example, hTR may localize to telomeres only during S phase when telomeres are synthesized (Ten Hagen et al., 1990; Wright et al., 1999) .
Evidence for this notion comes from important work done in ciliates that showed that a small fraction of telomerase RNA is mobilized during S phase to the replication band, the site of telomere synthesis (Fang and Cech, 1995) . At all stages of the cell cycle (including S phase) the majority of detectable ciliate telomerase RNA is present at intranuclear foci (that may include Cajal bodies) (Fang and Cech, 1995) .
In both cilates (Fang and Cech, 1995) and human cells (this study), much of the telomerase RNA appears to be in intranuclear structures and sequestered away from telomeres. Regulated movement of hTR (or assembled telomerase) out of Cajal bodies during S phase may be necessary for telomere synthesis. Several properties of Cajal bodies suggest that they may deliver telomerase to telomeres.
Cajal bodies undergo cell-cycle related structural changes (Andrade et al., 1993; Carmo-Fonseca et al., 1993; Chan et al., 1994; Boudonck et al., 1998; Liu et al., 2000) , are highly motile structures (Boudonck et al., 1999; Platani et al., 2000; Platani et al., 2002) , and are known to associate with specific chromosomal loci (reviewed in (Matera, 1998; Gall, 2000) ).
Telomerase and Nucleoli
Previous studies have proposed that the association of hTR and hTERT takes place within the nucleolus. A fraction of both hTERT (Etheridge et al., 2002; Wong et al., 2002; Yang et al., 2002) and hTR (Mitchell et al., 1999a; Narayanan et al., 1999; Lukowiak et al., 2001) localizes to nucleoli (as well as Cajal bodies).
Furthermore, the nucleolus is well-known as the site of assembly of the ribosome and perhaps other small RNPs (Pederson, 1998; Olson et al., 2002; Gerbi et al., 2003) . While we did not detect hTR in nucleoli in this study, it is possible that hTR transiently localizes to nucleoli where assembly occurs.
A recent study indicates that the intranuclear distribution of ectopically expressed hTERT may shift between nucleoli and the nucleoplasm in response to a variety of stimuli (Wong et al., 2002) . The authors propose that nucleolar localization provides a means to sequester active telomerase away from nucleoplasmic telomeres. The model is based on the assumption that the nucleolar hTERT is part of active telomerase complexes (and not unassembled hTERT molecules).
However, nucleolar targeting of hTERT occurs in human cells that do not express hTR (Etheridge et al., 2002) indicating that unassembled hTERT accumulates in nucleoli. In addition, the fraction of hTR that may be in nucleoli is very small; it is undetectable by FISH (this study) and was estimated as ~7% of total hTR by biochemical fractionation analysis (Mitchell et al., 1999a ). Thus, it seems possible that the hTERT observed in nucleoli does not represent active telomerase.
It will be important to precisely elucidate the steps along the telomerase biogenesis pathway and to understand how each step is coordinated in the cell both temporally and spatially to control the availability of functional telomerase. 
